{"cik":1778922,"taxonomy":"us-gaap","tag":"OperatingLeaseRightOfUseAsset","label":"Operating Lease, Right-of-Use Asset","description":"Amount of lessee's right to use underlying asset under operating lease.","entityName":"SpyGlass Pharma, Inc.","units":{"USD":[{"end":"2024-12-31","val":3291000,"accn":"0001778922-26-000020","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26","frame":"CY2024Q4I"},{"end":"2025-12-31","val":1552000,"accn":"0001778922-26-000020","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26"},{"end":"2025-12-31","val":1552000,"accn":"0001778922-26-000035","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14","frame":"CY2025Q4I"},{"end":"2026-03-31","val":1490000,"accn":"0001778922-26-000035","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14","frame":"CY2026Q1I"}]}}